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Abstract 
Objectives: To compare single dose with multiple dose 
antibiotic prophylaxis with Cefuroxime in open 
cholecystectomy in terms of post operative surgical site 
infection, hospital stay and cost effectiveness.  
Study Design:  Quasi experimental study.  
Place and Duration of study: The study was 
conducted in the Surgical Unit of Punjab Employees Social 
Security Institution Islamabad and Ahmed Hospital 
Rawalpindi Teaching Hospitals of IMDC Islamabad, from 
1st August 2010 to 30th September 2011.  
Methodology:  A total of one hundred and ten 
patients requiring elective open cholecystectomy were 
included. Patients with acute cholecystitis, jaundice, 
diabetes, malignancy, choledocholithiasis and co 
morbidity were excluded. Patients were divided in to two 
groups, 55 patients in each group, Group A received only 
single dose of Cefuroxime and Group B received multiple 
doses (six).   
Results: In this study, 97 (88%) patients were females 
and 13 (12%) were males. The mean age was 40.69 years. In 
Group A, 4 (5.5%) patients, and in Group B, 7 (12.7%) 
patients developed surgical site infection. Mean hospital 
stay in Group A was 2.18 days and in Group B 2.43 days. 
Cost of antibiotics in Group A was six times less than 
Group B.  
Conclusion: There is no difference in single dose and 
multiple doses prophylaxis with Cefuroxime in low risk 
patients for elective open cholecystectomy in terms of post 
operative surgical site infection and hospital stay however 
single dose is more cost effective.  
Key words: Open Cholecystectomy, Single dose, 
Prophylaxis, Cefuroxime 
 
Introduction 
Cholelithiasis is very common problem in general surgery 
practice all over the world. In Pakistan the overall incidence 
of Cholelithiasis is 9.03%.1 Cholelithiasis affects 
approximately 10% of the adult population in the United 
States.2 
Currently, the most frequently performed operation for 
symptomatic gall stones and cholecystitis is laparoscopic 
cholecystectomy in developed countries. Open 
cholecystectomy involves major abdominal surgery and is 
used as the first line treatment where laparoscopic facilities 
are not available.3-4 
Wound infection is not a new problem; it has been 
documented for at least 4000-5000 years. Egyptians had 
some concept of infection. The concept of prophylaxis had 
also been known earlier by Assyrians. Greeks independently 
explained it and later on Hippocratic teaching described the 
use of antimicrobials.5 
In abdominal surgery, infectious complications are the main 
causes of postoperative morbidity and financial cost.6 
Although surgical infection rate has decreased dramatically 
during the last 25 years, morbidity and mortality of these 
infections in surgical treatment remains substantial.7 The 
incidence of  surgical site infections in general surgery is 
related to many factors, and the main risk factors for 
developing infections are: endogenous, host-related, 
exogenous, procedure and environment related.8 Therefore, 
antibiotics have long been used in surgery, for prevention 
and treatment of infections. The World Health Organization 
has established the rationale of use of antibiotics as a 
priority in its campaign.9 Peri-operative antibiotic 
prophylaxis is safe and its effectiveness is proven.10,11 
Inappropriate use of surgical antibiotic prophylaxis is 
common, e.g., incorrect timing, improper duration, and oral 
route of administration of antibiotics.12 The timing of first 
dose is very important7, and improper timing is one of the 
most common faults regarding surgical prophylaxis.13 The 
agent selected should be the one to which the expected 
organisms are highly sensitive14, and the dose should have 
large volume of distribution, lower toxicity, and longer half-
life, allowing single dose administration. 
The effectiveness of prophylactic antibiotics in elective 
cholecystectomy is well-established and the choice of 
antibiotic remains a concern. Cholecystectomy is a  clean 
contaminated type of surgery and with prophylaxis surgical 
site infection is less than 10% and without prophylaxis  
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surgical site infection can be up to 20%.5 The source of 
infection can be endogenous (infected bile/gallbladder wall) 
or exogenous. In certain trials, the frequency and type of 
bacteria in bile, the factors predicting the presence of 
bacteria in bile, and the relationship between bacteria in bile 
and subsequent wound sepsis have been evaluated.15-16 
In this article we report the use of second generation 
cephalosporin (Cefuroxime), as mentioned in the text17, for 
prophylaxis and comparison of single dose with multiple 
doses of intravenous Cefuroxime in terms of wound 
infection, hospital stay and cost effectiveness. 
 
Material and Methods 
It was a Quasi Experimental study. The study was 
conducted in the Surgical Unit of Punjab Employees Social 
Security Institution Islamabad and Ahmed Teaching 
Hospital of Islamabad Medical & Dental College, from 1st 
August 2010 to 30th September 2011. Total 110 patients 
without any gender discrimination were included in the 
study with chronic cholecystitis due to gall stones or 
acalculous choric cholecystitis or symptomatic gall stones. 
Age of the patients ranged from 20 to 65 years. Patients with 
acute cholecystitis, choledocholithiasis, malignancy, co 
morbid like diabetes, hypertension, hepatitis, jaundice, 
chronic renal failure and history of pancreatitis were 
excluded from the study. All the patients were admitted 
through the OPD in the surgical ward for open 
cholecystectomy. Permission was taken from the Hospital 
ethical committee for the study. The patients were 
thoroughly examined in the wards and all the routine and 
specific investigations done to confirm the diagnosis. 
Detailed informed consent was taken. The patients were 
divided into two groups Group A and B by randomization 
selection. In group A patients were given 750 mg of 
Cefuroxime intravenously, one hour before induction of 
anesthesia. In group B, multiple doses of 750 mg of 
Cefuroxime were given intravenously; first dose at 1 hour 
before induction of anesthesia, and subsequent doses were 
given at an interval of 8 hours after surgery for 2 days (six 
doses). After operation, the patients were observed for 
postoperative sepsis in the ward for two days 
Table 1: Grades of Wound Infection 
Grade-I 
infection 
Slight reddening and induration of wound 
edges requiring no intervention. 
Grade-II 
infection 
Slight serous discharge from wound, 
requiring no intervention 
Grade-III 
infection 
Obvious infection or purulent discharge 
from wound, requiring repeated change of 
dressings and institution of antibiotics 
 
. Daily record of pulse, temperature, respiratory rate, 
abdominal tenderness, and bowel sounds was maintained. 
Blood complete picture was done on 2nd post op day and 
wound was examined before discharging the patient. 
Subsequently, the patients were observed on the 5th, 7th, 15th, 
21st and 30th day, in surgical outpatient department, for 
wound infection and fever. Wound infection was 
categorized into three grades depending on severity (Table 
I): 
The data was collected on a preformed proforma and entered 
into SPSS software version 16 and analyzed. Mean ± 
standard deviation will be calculated for age and hospital 
stay. Frequencies and percentages were calculated for 
gender and wound infections in both groups. Chi square test 
was used to compare the frequency of wound infection in 
group A and Group B patients. P-value <0.05 was 
considered significant. 
 
Results 
In a total number of 110 patients included in the study, the 
age ranged from 20 years to 65 years with a mean + SD of 
40.69 + 7.76 years. Maximum number of patients was in the 
age group of 36 to 45 years (Figure I). There were 97 (88%) 
females and 13 (12%) male patients.  
 
 
Figure 1: Distribution of Patients by Age Groups 
 
In Group A, 3 patients (5.5%) developed Surgical Site 
Infection, while 52 patients had normal wound healing; 2 
patients developed Grade II infection, while one patient 
developed Grade III infection. In Group B, 7 patients 
(12.7%) developed surgical site infection; of them, 1 patient 
developed Grade I, 4 patients developed Grade II and 2 
patients developed Grade III infection. (Figure 2) On 
comparing the results of both Groups by applying Chi 
Square test a value 0.990 was obtained which was 
insignificant. 
Mean hospital stay in the Group A patients was 2.18 days 
with Standard Deviation (SD) of ± 0.181, while Mean 
hospital stay in the Group B patients was 2.43 days with 
Standard Deviation (SD) of ± 1.21  
In terms of cost effectiveness the cost of antibiotics in 
Group B were 6 times more as compare to Group A.  
 
Discussion 
Gall stones are a very common problem in every part of the 
world and cholecystectomy is most common procedure in 
surgical settings.2 In developed countries and institution 
where facilities of laparoscope are available, laparoscopic 
cholecystectomy is the procedure of choice. Open 
cholecystectomy is still first line of treatment where 
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facilities, cost effectiveness and expertise matter.3 Leo and 
colleagues published a study in 2006 and discussed the open 
cholecystectomy for gall bladder disease and concluded this 
procedure as effective, compatible with short hospital stay, 
evidence-based gall-bladder surgery, and training of surgical 
residents.18   Cholecystectomy is clean contaminated type of 
procedure, and wound infection without prophylaxis can 
affect 20% of individuals.5 Prophylaxis is still a debatable 
issue and different studies are conducted on the issue.19 Pea 
and colleagues published a study in 2003 and advised 
second generation cephalosporin prophylaxis for clean 
contaminated cases for ultra short period and also 
recommended that post surgical prophylaxis is not 
advisable.20 Similarly the concept of chemoprophylaxis 
which is the base of our study is also recommended by the 
Bowater and his colleagues in the study published in 2009. 
They concluded that the prophylaxis is effective in post 
operative wound infections.21     
 
Figure 2: Frequency and Grades of Wound Infections in 
Both Groups 
 
The results of our study showed that females were mostly 
affected by the gall bladder disease (88%) as compared to 
males (12%). The results of gender frequency of our study 
are similar to a previous study published in 2008 , showing 
that incidence of  gallbladder disease among females in 
Pakistan is 3.3 time more as compared to males.1   
 The results of our study showed that the 3 patients (5.5%) 
developed wound infection in Group Amongst these 
patients,  2 patients developed Grade II, and one patient 
developed Grade III wound infection; all the patients in this 
group were receiving single dose of Cefuroxime for 
prophylaxis. In Group B which was receiving multiple doses 
for prophylaxis, 7 patients (12.7%) developed wound 
infection. In this group one patient had Grade I, 4 patients 
had Grade II and 2 patients had Grade III wound infections. 
On comparing the results of both groups the p value had 
showed statistically insignificant result, but clinically the 
Group A had better results as compared to the Group B. 
Compliance of the patients were also better in Group A as 
compared to Group B.  In a previous study, Zahid et al 
compared the results of single dose versus three-dose 
prophylaxis by cefotaxime sodium in patients undergoing 
elective cholecystectomy. The results were like our study; 
single dose group had 4% wound infection, while three 
doses group had 5.3% wound infection. The authors 
recommended single dose antibiotic prophylaxis with 
cefotaxime.22    
Another study showed 4.3% wound infection with single 
antibiotic in two doses, and recommended single antibiotic 
prophylaxis for elective cholecystectomy.23  
Kufman conducted a double blind, controlled randomized 
trial to evaluate the effectiveness of a single dose of 
prophylactic antibiotic (gentamycin) for elective 
cholecystectomy. All patients recognized pre-operatively as 
being at risk were excluded. The treatment group comprised 
of 102 patients received a single dose of antibiotic and the 
74 patients in the control group received a placebo. Of the 
patients who received antibiotic, wound infection developed 
in 4.9% as compared to13.5% in the control group.24 
Mean hospital stay in our study was 2.18 days for Group A 
patients and 2.43 days for Group B patients which were 
slightly high as compared to the study conducted by Leo and 
colleagues18, but our results are better as compare to study 
conducted by Zahid.22 
In our study cost of antibiotics of Group A is simply six 
times less with Group B that is also major concern for the 
underdeveloped countries and for patients also.  
 
Conclusion 
There is no difference in single dose and multiple doses 
prophylaxis with Cefuroxime in low risk patients for 
elective open cholecystectomy in terms of post operative 
surgical site infection and hospital stay. The risk of 
postoperative wound infection can be effectively managed 
by single dose prophylactic antibiotic (Cefuroxime). The 
single dose prophylaxis also has the benefit of cost 
effectiveness. We recommend large scale multi centre 
studies in Pakistan to augment our conclusion.   
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